Contract Economics Can Limit Device Expansion

A group purchasing agreement can make a medical device available to more hospitals, but wider access can put unexpected pressure on the manufacturer’s margins and service capacity. The contract may look commercially promising when it is signed. Problems begin when supporting the resulting accounts costs more than the company had planned.

The negotiated price is only part of that cost. Managing the agreement may involve regular reporting and   documentation. Product updates must be communicated, and purchasing terms need continued attention. A manufacturer that focuses only on the unit price can easily underestimate how much work the contract will require.

Orders may not arrive in the pattern the company expects either. Access to a large GPO network does not produce steady purchasing volume. One hospital might begin with a limited evaluation. Another may ask for product support before deciding whether to place an order. Even a small initial purchase can demand considerable time from sales or clinical staff.

Emerging device companies face a difficult balance here. Hospitals need enough support to introduce the product properly, but providing extensive assistance to every low-volume account can reduce the return from those sales. The commercialization plan should make clear what support is included and when an account justifies additional resources.

Contract terms should also reflect how the device reaches the hospital. Selling directly creates a   different cost structure from working through a distributor. The chosen route affects both the manufacturer’s margin and its control over the customer relationship. Companies using multiple channels must be careful that their pricing arrangements do not conflict and make the device harder to sell.

GPO membership numbers can also lead to unrealistic demand forecasts. A large network represents   possible access, not a reliable estimate of how many hospitals will evaluate the device. If the forecast treats every eligible facility as a likely customer, the manufacturer may add employees or increase inventory before actual demand becomes clear.

Being too cautious creates a different problem. A company may keep inventory low while waiting for   firmer orders. If adoption develops faster than expected, fulfillment delays can disrupt relationships with hospitals during the first stage of use. The contract plan needs room for uneven demand without assuming that every member facility is about to place an order.

Revenue alone will not show whether the agreement is working. A contract can generate sales but still produce a weak return once account support and administrative work are included. Another agreement may bring in modest revenue at first, yet provide access to facilities that become regular customers later. The manufacturer needs enough account-level information and time to tell the difference.

Renewal discussions offer an opportunity to test the assumptions made when the contract was signed. The company can compare purchasing activity with the resources used to support the agreement. It may then need to revise its pricing or set clearer service limits. The types of hospitals being pursued may also warrant another look. Contract management continues well beyond the initial negotiation.

A GPO strategy should make hospital expansion financially workable, not simply increase the number of  facilities allowed to buy the device. Broad access offers limited benefit when each new account adds more cost than the business can carry. Manufacturers need to know whether the agreement can support a viable customer base, not merely whether it places the product within reach of more hospitals.